Background/Aims: Carbon monoxide (CO) is an important autocrine/paracrine messenger involved in a variety of physiological and pathological processes. This study aimed to investigate the regulatory role of CO released by CO-releasing molecule-2 (CORM-2) in a P2Y receptormediated calcium-signaling pathway in the human bronchial epithelial cell line, 16HBE14o-. Methods: Intracellular calcium ([Ca 2+ ] i ) was measured by fura-2 microspectrofluorimetry. D-myo-inositol-1-phosphate (IP 1 ) levels and cGMP-dependent protein kinase activity (PKG) were also quantified. Results: The exogenous application of CORM-2 increased both intracellular Ca 2+ and IP 1 , which are inhibited by U73122, a phospholipase C (PLC) inhibitor. In contrast, the P2Y 2 /P2Y 4 receptor-mediated intracellular Ca 2+ release and influx induced by UTP were inhibited in the presence of CORM-2. However, CORM-2 did not affect the storeoperated Ca 2+ entry (SOCE) induced by thapsigargin (Tg). Moreover, the inhibitory effect of CORM-2 on UTP-induced calcium increase could be attenuated by a soluble guanylyl cyclase (sGC) inhibitor, 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ), or a Protein Kinase G (PKG) inhibitor, KT5823, suggesting the involvement of sGC/PKG signaling in this process. Conclusion: CORM-2 serves a dual role in modulating [Ca 2+ ] i in 16HBE14o-cells. Thus, CO released by CORM-2 may act as a regulator of calcium homeostasis in human airway epithelia. These findings help further elucidate the function of CO in many physiological and pathological conditions.
Introduction
Carbon monoxide (CO) is a potent gas molecule with a variety of physiological functions, including vasodilation, anti-inflammation, anti-oxidative stress, and neuromodulation [1] . CO is produced endogenously by the heme oxygenase (HO) enzymes HO-1, HO-2, and HO-3. HO-2 and HO-3 (only expressed in rats) are constitutively expressed, whereas HO-1 is induced by a wide range of stimuli [2, 3] . Both HO-1 and HO-2 are reportedly expressed in human airway epithelial cells [4] . The measurement of the rate of endogenous CO production in humans using blood carboxyhemoglobin (CO-Hb) analyses was first described by Coburn et al. and was found to be ~0.42 ml/hr [5] . Endogenously produced CO is sufficient to maintain a COHb saturation level of 0.4-0.96% [6] . This CO-Hb level can be elevated to 5% or even higher in heavy smokers [7] . Although it has been demonstrated that CO is a potential therapeutic agent in different animal models of inflammatory disease [8, 9] , increasing the CO-Hb level to 7% by CO inhalation had no anti-inflammatory effects in a systemic lipopolysaccharideinduced inflammation model in humans [10] . Therefore, further clinical experiments are required to investigate the safety and efficacy of CO inhalation as a treatment for human inflammatory lung diseases.
To provide safe and controlled delivery of CO into cells, CO-releasing molecules (CORMs) have been developed and tested over the past decade [11] . CORM-2, a lipidsoluble metal carbonyl complex tricarbonyl dichlororuthenium (II) dimer ([Ru(CO) 3 Cl 2 ] 2 ), is commonly used experimentally to release CO and to elicit various biological activities such as a vasodilatory effect on rat aortic rings [12] , an anti-inflammatory effect in murine macrophages [13, 14] , and an anti-bacterial effect [15] . By measuring the conversion of deoxymyoglobin to carbonmonoxy myoglobin spectrophotometrically, it has been estimated that for each mole of CORM-2, approximately 0.7 moles of CO are rapidly released with a half-life of about 20 minutes [12] .
P2Y receptors are expressed in virtually all epithelia, where they are activated by extracellular nucleotides such as ATP and UTP [16] and control the transport of fluid and electrolytes. Eight P2Y receptor subtypes have been defined. We previously reported four subtypes of P2Y receptors (P2Y 1 , P2Y 2 , P2Y 4 , and P2Y 6 ) expressed in human bronchial epithelial cell line 16HBE14o-. 16HBE14o-cells are an immortalized cell line that was derived from the human bronchial surface epithelium [17] . These cells represent a good model for investigating transepithelial Cl -secretion [18, 19] , airway inflammation, and airway remodeling [20] [21] [22] . Our previous studies showed that activation of P2Y receptors regulated epithelial Cl -secretion via both Ca
2+
-and cAMP-dependent pathways [23] and activated the PLC-D-myo-inositol 1, 4,5-triphosphate (IP 3 )-Ca 2+ signaling cascade in 16HBE14o-cells, which is also responsible for the secretion of at least two pro-inflammatory cytokines, interleukin (IL)-6 and IL-8, when the cells were challenged by cationic proteins [24] . Therefore, we sought to test whether CO would modulate the P2Y receptor-mediated calcium-signaling pathway.
Calcium ions (Ca
) impact nearly every aspect of life; therefore, calcium signaling and Ca 2+ levels are highly controlled [25] . Intracellular Ca 2+ may come from either calcium release from intracellular Ca 2+ stores, such as the endoplasmic reticulum (ER), and/or Ca 2+ influx. In electrically non-excitable cells, the major Ca 2+ entry pathway is reported to be storeoperated calcium entry (SOCE) [26] . However, there is substantial evidence that a non-storeoperated calcium entry pathway, known as receptor-operated calcium entry (ROCE), may exist. Although ROCE is well studied in excitable cells, it also exists in non-excitable cells [27, 28] . Therefore, it is possible that the activation of P2Y receptors could activate both SOCE and ROCE in human bronchial epithelia; thus, it would be interesting to test if CORM-2 has any effect on SOCE and/or ROCE. Although some reports suggest that CO maybe a regulator of ion channels [29] , and that CO can inhibit T-type calcium channels in neuronal cells [30] and affect calcium signaling in pancreatic acinar cells [31] , the regulatory effects of CO on intracellular calcium in human airway epithelia remain largely unknown. To our knowledge, this is the first study to examine the effect of CO released by CORM-2 on Ca 2+ signaling and its interaction with the purinergic signaling pathway in human bronchial epithelial cells.
Materials and Methods
Cell culture 16HBE14o-cells were maintained in Minimum Essential Medium with Earle's salt supplemented with 10% (vol/vol) fetal bovine serum, 1% (vol/vol) L-glutamine, 100 IU/ml penicillin, and 100 μg/ml 2+ -free KH was the same as normal KH with the exception that there was no CaCl 2 in the solution.
IP 1 assay
Because the lifetime of IP 3 within the cell is very short before it is transformed into IP 2 and IP 1 , IP 1 accumulation levels can be used to represent IP 3 levels in cells [32] . The IP 1 measurements were performed as recently described [32] . Agonist-induced IP 1 in LiCl-treated cells was quantified using the Cisbio IP-One kit (Cisbio Bioassays, Codolet, France) per the manufacturer's instructions. Light emitted at 615 and 665 nm was measured on a Spectra Max i3X Multimode Plate Reader (Molecular Devices, CA, USA) using the HTRF mode after excitation at 340 nm. The FRET ratios (665 nm/615 nm) were converted to concentrations of IP 1 using the provided standard.
PKG activity assay
Cells were grown in 35mm cell culture dishes (SPL Life sciences Co. Ltd, Korea). Cells were incubated in serum-free medium overnight after they reached confluence. Cells were then treated with either CORM-2 or RuCl 3 , the negative control for CORM-2, for 15 min. KT5823 was applied 10 min before CORM-2 treatment. Protein was extracted using standard methods. Protein (50 µg) was added to each well for further assay. The PKG activity assay was performed using the Cylex cyclic GMP-dependent protein kinase assay kit (MBL, USA) as previously described [33] .
Materials
All chemicals were acquired from Sigma-Aldrich (St. Louis, MO, USA), and all cell culture reagents were obtained from Invitrogen (Carlsbad, CA, USA).
Data analyses
Data are presented as mean ± standard error (S.E.) and the values of n refer to the number of experiments in each group. Statistical comparisons were performed using either a Student's t-test or oneway ANOVA (followed by post hoc tests). A p< 0.05 was considered significant. 2+ ] i ] i was concentration-dependent, with an EC 50 of 52.7 ± 0.5 µM as shown in Fig. 1B . The inactive form of CORM-2, iCORM-2 (100 µM), had no significant effect (Fig. 1C) -free KH solution (Fig. 1C) . The summarized data are shown in Fig. 1D . The results indicated that the calcium increase induced by 100 µM CORM-2 was mainly due to Ca 2+ entry from the extracellular medium. To test whether calcium entry induced by CORM-2 is mediated by the emptying of Ca 2+ stores by the PLC-IP 3 signaling pathway, the cells were stimulated with CORM-2 (100 µM) at time 0 min in the presence of the PLC inhibitor U73122 (Fig. 1C) . In the presence of U73122 (10 µM), the CORM-2-induced Ca 2+ increase was almost completely abolished (CORM-2, change in ratio = 2.18 ± 0.18; CORM-2 + U73122, change in ratio = 0.45 ± 0.23; p< 0.05, n = 4; Fig. 1D ).
Results

CORM-2 caused an increase in [Ca
To study the involvement of different Ca 2+ entry pathways in CORM-2-mediated calcium increase, two calcium entry blockers, N- (E) 16HBE14o-cells were superfused with normal KH solution and then stimulated with CORM-2 and treated with Pyr-6 (10 µM), 2-APB (10 µM),) or both after the CORM-2-induced calcium changes had reached peak levels. Inhibition was calculated as a percent relative to the maximal increase in the Fura-2 ratio induced by CORM-2 in the presence of Pyr-6, 2-APB, or both (n = 3-5). [35] and TRP channel-mediated calcium entry [36] . In addition, the IP 3 receptormediated calcium release can also be suppressed by 2-APB [37] . Figure1E shows the percent inhibition of the CORM-2 induced Fura-2 ratio by Pyr6 and 2-APB. The cells were stimulated with CORM-2 (100 µM) and Pyr6 (10 µM) and/or 2-APB (10 µM) was added once the CORM-2-induced calcium levels had reached the maximum level. When Pyr6 (10 µM) was added at the peak of the CORM-2-induced Ca 2+ increase, it suppressed 34.0% ± 8.6% (before Pyr6, change in ratio = 2.06 ± 0.20, n = 5; after Pyr6, change in ratio = 1.43 ± 0.13, n = 3) of the maximal calcium response (Fig.  1E ). However, 2-APB alone largely reduced the CORM-2-induced Ca 2+ increase (after 2-APB, change in ratio = 0.78 ± 0.07, n = 5; % inhibition = 61.6% ± 6.0%). The % inhibition increased to 82.7% ± 1.6% (after Pyr6 + 2-APB, change in ratio = 0.28 ± 0.06, n = 3) when both Pyr6 and 2-APB were present. Taken together, these results indicate that CORM-2-induced calcium signaling involves the activation of the PLC/IP 3 pathway and the involvement of the Pyr-6-or 2-APB-sensitive calcium entry pathway.
CORM-2 induced IP 3 production
Because the PLC inhibitor abolished the calcium increase induced by CORM-2, it is likely that CORM-2 could induce IP 3 production via the PLC/IP 3 signaling cascade. To examine the activity of PLC, 16HBE14o-cells were stimulated with different concentrations of CORM-2 for 1 hr and IP 1 , a non-degradable stable product of IP 3 , was measured. Our results indicated that CORM-2 induced IP 1 formation in a concentration-dependent manner with an EC 50 of 9.98 µM ( Fig. 2A) . For the positive control experiment, activation of P2Y 2 /P2Y 4 receptor by UTP caused an increase in IP 1 formation, which could be inhibited by U73122 (Fig. 2B) . Similarly, U73122 abolished IP 1 accumulation induced by CORM-2 ( Fig. 2B) , indicating that CORM-2 could activate the PLC/IP 3 signaling cascade. iCORM-2 has no significant effect on IP 1 formation.
CORM-2 suppressed UTP-induced calcium increase
To test whether CORM-2 has an effect on G protein-coupled receptor-mediated Ca 2+ signaling, the cells were stimulated with UTP (a P2Y 2 /P2Y 4 receptor agonist) in the absence or presence of 30 µM CORM-2 (Fig. 3A) . At this concentration, CORM-2 did not induce a significant increase in [Ca 2+ ] i as shown in Fig. 1A . CORM-2 suppressed the calcium increase induced by 5 µM UTP in a concentration-dependent manner, with an IC 50 of 11.45 µM (Fig.  3B) . We further studied whether CORM-2 inhibited the P2Y receptor-mediated calcium release and/or influx component in 16HBE14o-cells using an extracellular Ca 2+ removal/readdition protocol as previously described [38] . The control experimental protocol involved stimulating the cells with UTP in a Ca 2+ -free solution to deplete the internal Ca 2+ stores, after (Fig. 3C) . In another series of experiments, the same protocol was applied but the cells were perfused with different concentrations of CORM-2, as indicated, to determine its effect on UTP-induced calcium release and influx component. These results demonstrate that both calcium release (Fig. 3D) and influx (Fig. 3E) could be inhibited by CORM-2 in a concentration-dependent manner with an IC 50 of 9.39 and 7.75 µM, respectively.
The inhibitory effect of CORM-2 on UTP-induced calcium influx was not due to the decreased calcium release
Although it is clear that both the calcium release and influx induced by UTP were inhibited by CORM-2, it is possible that the suppressed calcium influx was due to impaired calcium release and retention of Ca 2+ in calcium stores. Therefore, a similar protocol as described in Fig. 3C was used, but CORM-2 was added after the UTP-induced calcium release from ] i returned to basal levels, external Ca 2+ was subsequently restored (2 mM) (n = 5-7). Summarized data demonstrate CORM-2 concentration-dependently inhibited both calcium release (D) and calcium influx (E). Each data point represents the mean ± S.E. for 5 -7 experiments. Fig. 4A shows that CORM-2 (30 µM) was still capable of inhibiting calcium influx (33.4% ± 14.9% of control) despite no significant change in the calcium release component (control, change in ratio = 1.12 ± 0.13; CORM-2, change in ratio = 1.09 ± 0.12; p>0.05, n = 5) upon UTP stimulation. In the absence of CORM-2 (control), the UTP-induced increase in the Fura-2 ratio associated with the calcium influx was 1.09 ± 0.16. Fig. 4B shows that this inhibitory effect of CORM-2 on the UTP-induced calcium influx was concentrationdependent with an IC 50 of 12.41 µM (Fig. 4B ).
Figure 3
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CORM-2 had no inhibitory effect on SOCE
SOCE is assumed to be a major ubiquitous pathway for calcium entry in non-excitable cells, such as epithelial cells [26] . Thapsigargin (Tg), a specific ER Ca 2+ -ATPase inhibitor [39] , was used as a pharmacological tool to deplete the internal calcium store and to bypass the receptors and the subsequent signaling cascade to activate SOCE. In the absence of extracellular Ca 2+ , Tg (1 µM) induced the emptying of intracellular Ca 2+ stores, and a calcium influx occurred upon restoring extracellular Ca 2+ in the perfusate (Fig. 5A and C) . We examined the effects of CORM-2 on SOCE by incubating the cells with CORM-2 throughout the entire experimental period (Fig. 5A ) or after calcium stores had been depleted by Tg (Fig. 5C ). CORM-2 did not affect calcium released by Tg (Fig. 5B) . Calcium entry after store depletion was not significantly different between control and CORM-2-treated cells (Fig. 5B  and D) in either protocol. Together with previous data, these results suggest that the P2Y receptor-induced calcium entry pathway inhibited by CORM-2 is different from the SOCE activated by Tg.
UTP-induced calcium influx was insensitive to SOCE inhibitor
To distinguish between SOCE and UTP-induced ROCE, Pyr6 and 2-APB were used to differentiate the two different calcium influx pathways. The cells were stimulated with UTP in Ca
2+
-free solution to deplete the intracellular Ca 2+ stores, followed by the addition of Ca 2+ back into the perfusion solution in the continued presence of UTP. The non-specific calcium entry blocker, 2-APB, almost completely suppressed the P2Y receptor-mediated calcium entry (Fig. 6A , red trace) when compared to the control cells (black trace). The addition of 2 mM calcium to the perfusion solution induced only a minimal increase in calcium entry (control: change in ratio = 0.72 ± 0.09, n = 7; + 2-APB, change in ratio = 0.07 ± 0.06, n = 3, p < 0.05; % inhibition = 90.8% ± 6.1%). In contrast, Fig. 6B shows that the SOCE specific inhibitor, Pyr6, had no significant effect on the ROCE activated by UTP (+ Pyr6: change in ratio = 0.67 ± 0.22, n = 4, p>0.05). On the other hand, the SOCE activated by Tg was sensitive to both 2-APB ( Fig. 6C ) and Pyr 6 (Fig. 6D ). The addition of 2-APB or Pyr6 to the cells when the Tg-induced calcium influx had reached a plateau caused a rapid decline in the Fura-2 ratio towards the 2+ removal/addition protocol similar to that described in Fig. 3 . was used. However, CORM-2 was added after the UTP-induced Ca Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry pre-stimulated level. When compared with the Fura-2 ratio at the same time point when the calcium levels in the control cells reached a steady level, the percent inhibition of 2-APB and Pyr6 on the Tg-induced calcium influx was 83.4% ± 6.6% (control,: change in ratio = 2.41 ± 0.05, n = 8; + 2-APB, change in ratio = 0.33 ± 0.18, n = 5, p < 0.05) and 74.2% ± 7.7% (+ Pyr6, change in ratio = 0.47 ± 0.14, n = 3, p < 0.05), respectively. The data clearly demonstrate that UTP-induced calcium influx was different from typical SOCE. To examine whether UTP can affect the Tg-sensitive calcium stores, Tg was added after the UTP-induced calcium increase returned to basal level (Fig. 7A ). An increase in calcium was observed, and the ratio change of Tg-induced calcium increase was not statistically different from that of the control (in the absence of UTP; Fig. 7B ). These data indicate that 5 µM UTP was not sufficient to deplete the Tg-sensitive intracellular calcium stores. 
Figure 8
The inhibitory effect of CORM-2 on P2Y receptormediated calcium increase was sGC/PKG dependent Carbon monoxide is known to activate the sGC/ PKG pathway [1] . Therefore, we examined whether sGC/PKG is involved in the inhibitory effect of CORM-2 on P2Y receptor-mediated calcium signaling. Fig.  8A shows that CORM-2 suppressed UTP-induced calcium increase significantly (blue trace). However, this inhibitory effect was attenuated by 100 µM ODQ, a sGC inhibitor (red trace), or 5 µM KT5823, a PKG inhibitor (green trace). In the presence of CORM-2, UTP-induced calcium increase was only 34.5% ± 0.7% compared to that of the control, and this percentage increased to 70.6% ± 6.4% and 77.5% ± 7.7% when ODQ or KT5823 was present, respectively (Fig.  8B) . Treatment with CORM-2 led to increased PKG activity (1.47 ± 0.08 -fold vs. control), and this effect could be blocked by KT5823 (1.13 ± 0.04 -fold vs. control). The CORM-2 negative control, RuCl 3 , had no effect on PKG activity (Fig. 8C) .
CORM-2 and UTP did not have any additive effect on IP 3 formation
Because UTP-induced calcium increase was dependent on the PLC/IP 3 signaling pathway and because CORM-2 could also induce IP 1 formation, we examined whether UTP and CORM- 2 had an additive effect on the formation of IP 1 . Fig. 9 shows that UTP (10 µM) or CORM-2 (10 µM) alone, induced an increase in IP 1 formation. However, in the presence of both CORM-2 (10 µM) and UTP (10 µM), IP 1 formation did not differ significantly from that of UTP or CORM-2 alone. Similarly, the IP 1 formation induced by CORM-2 (100 µM) and UTP (10 µM) was not statistically different from that of CORM-2 alone. These data suggest that there was no additive effect of the combination of both CORM-2 and UTP on IP 1 formation, suggesting that CORM-2 and UTP may share a common pathway to induce IP 3 formation.
Discussion
This study demonstrated, for the first time, the regulatory effect of CO released by CORM-2 on calcium homeostasis in 16HBE14o-human bronchial epithelial cells. Although we did not directly measure the actual CO concentration in the solution bathing the cells, Motterlini et al. performed a series of elegant experiments to demonstrate that the CORMs, including CORM-2, rapidly liberate CO to elicit vasodilatory effects in rat aortic rings by measuring the conversion of deoxymyoglobin to carbonmonoxy myoglobin spectrophotometrically [12] . In this study, at higher concentrations (e.g., 100 µM), CORM-2 could induce a slow, yet long-lasting, calcium increase in human bronchial epithelial cells. This effect appeared to be dependent on the CO released by CORM-2 because iCORM-2, which did not liberate CO, had no effect on the calcium levels. The time course is similar to what was previously observed in rat pancreatic acinar cells when 100 or 300 µM of CORM-2 was applied to the cells [31] . However, in pancreatic cells, the [Ca 2+ ] i changes were found to be oscillatory at medium concentrations (0.4 -0.5 mM) in the extracellular solution, and monophasic (1 mM) at the highest concentration, which is typical of pancreatic acini cells when stimulated with physiological secretagogues such as CCK-8 or acetylcholine [31] . The fact that calcium increase induced by CORM-2 could be abolished in cells superfused with Ca 2+ -free KH solution or by pretreatment of the cells with PLC inhibitor U73122, suggests a joint participation of both intracellular calcium release and extracellular calcium entry. This is different from pancreatic cells in which the increase in [Ca 2+ ] i was predominately due to PLC/ IP 3 -triggered intracellular Ca 2+ mobilization [31] . CORM-2 could induce IP 1 accumulation in a concentration-dependent manner, and it is interesting to note that 10 µM CORM-2 almost induced the same amount of IP 1 production as that of 10 µM UTP, indicating that CO released by CORM-2 may be an effective PLC activator as compared to the activation of a G proteincoupled receptor. Because activation of the PLC/IP 3 pathway leads to intracellular calcium release, intracellular calcium stores of 16HBE14o-cells might be, at least partially, depleted upon CORM-2 treatment resulting in the activation of SOCE. Consistent with this hypothesis, both 2-APB and Pyr6 suppressed CORM-2-induced calcium increase (Fig. 1E ). Pyr6 only partially suppressed the calcium influx, and the rest may be due to other calcium entry pathways, such as PLC/diacylglycerol (DAG) activated calcium influx [40, 41] .
Although 100 µM CORM-2 induced more IP 1 production than UTP, CORM-2 induced only a minor release of calcium in a calcium-free solution (Fig. 1C and D) . One possibility is that CORM-2 induced the production of IP 3 in a relatively slow fashion and the newly produced [42] . The fusion protein binds to phosphatidylinositol 4, 5-bisphosphate (PIP 2 ) and IP 3 and allows the monitoring of IP 3 localization after PIP 2 cleavage regardless of the PLC isoform [42] . Future studies involving this advanced approach will be required to unravel the underlying mechanisms.
This study also revealed an inhibitory effect of CORM-2 on P2Y receptor agonist-induced calcium signaling. As shown in Fig. 3 and 4 , CORM-2 inhibited both calcium release and influx induced by UTP in a concentration-dependent manner. The inhibitory effect on calcium release was probably due to the fact that both agents share a common PLC pathway to induce IP 3 formation. CORM-2 also exerted a direct inhibitory effect on UTP-induced calcium influx, which was due to sGC/PKG signaling activated by CORM-2. As shown in Fig. 8 , inhibition of sGC or PKG reversed the inhibitory action of CORM-2 on UTP-induced calcium signaling. The cGMP signaling pathway is known to participate in vasodilation, which can be blocked by ODQ or KT5823 [43] . Similar to nitric oxide, CO is considered a major component in the regulation of cardiovascular circulation [44] via activation of the cGMP signaling pathway [45, 46] . Together with these reports, our data further confirm that sGC, which localizes to the cell surface, is one of the proximal targets for CO [11] .
Because the UTP-mediated Ca 2+ influx was not sensitive to Pyr-6 (Fig. 6B) , it is likely that CORM-2 could inhibit other calcium entry pathways, such as ROCE, which is activated by the P2Y receptor. Although it has been reported that CORM-2 inhibits L-type [47] and T-type [30] Ca 2+ channels, there is currently no evidence that 16HBE14o-cells express these two types of voltage-gated Ca 2+ channels. The finding that the activation of SOCE by Tg was not affected by 100 µM CORM-2 ( Fig. 5 ) was unexpected. In contrast, it has been shown that CO inhibits the capacitative calcium entry induced by Tg in human platelets [48] . CO also inhibits the calcium influx induced by ADP and thrombin, although it was not known whether the Ca 2+ entry was mediated through SOCE or ROCE [48] . On the contrary, CO released by CORM-2 enhanced the Tg-induced capacitative calcium entry in SH-SY5Y cells, a human neuroblastoma cell line, possibly by inhibiting Ca 2+ extrusion via plasma membrane Ca 2+ -ATPase through a nitric oxide-dependent increase in reactive oxygen species [49] . Therefore, CO causes diverse modulatory effects on the calcium entry pathway and the effect is probably cell-type specific.
To demonstrate the difference between SOCE and ROCE, 2-APB and Pyr6 were used. In the present study, Pyr6 only suppressed SOCE elicited by Tg, whereas 2-APB inhibited both the Tg-and UTP-induced calcium entry (Fig. 6) . Activation of P2Y receptors by UTP would also deplete intracellular calcium stores by activating IP 3 /calcium signaling, leading to the activation of SOCE. However, our data suggest that 5 µM UTP did not significantly deplete the Tg-sensitive calcium store, which is not sufficient to activate SOCE. As shown in Fig. 7 , the ratio change of Tg-induced SOCE was not significantly different in the control cells or when the cells were previously treated with UTP. Moreover, the P2Y receptormediated calcium influx component only occurred in the continuous presence of UTP (data not shown), suggesting that store depletion alone might not be sufficient to activate calcium entry. The second possibility is that the UTP-releasable Ca 2+ stores do not overlap with Tgreleasable calcium stores. Therefore, UTP was not able to activate SOCE as Tg. However, we have demonstrated previously that 10 µM ATP (P2Y 1 /P2Y 2 agonist) can stimulate the oligomerization and translocation of stromal interaction molecule 1 (STIM1) near the plasma membrane [32] . Also, 10 µM ATP induced a significant increase in STIM1 puncta formation in 16HBE14o-cells [32] . Therefore, the most likely explanation is that UTP activates a calcium entry pathway that is truly distinct from SOCE. However, the detailed molecular mechanism underlying the inability of UTP to induce Pyr6-inhibitable SOCE remains unresolved. Some studies suggest that TRP cation channels formed ROCE [50, 51] . Among the TRP channels, the TRPC family was indeed a perfect candidate to form ROCE; TRPC2, 3, 6, and 7 can be activated by DAG, a potent lipid messenger produced from PIP 2 by PLC activation, and activation of TRPC4 and 5 was PLC-dependent [52] . In mouse airway epithelial cells, TRPV4 participated in ROCE instead of SOCE [27] , further indicating the possible involvement of TRP channels in ROCE. However, reports on the effects of CO on TRP channels are scarce. The molecular identity of ROCE activated by UTP remains unknown and requires further investigation.
In the future, it will be important to measure the real-time changes in CO levels inside living cells in the presence of CORMs and to correlate CO levels with their biological activities, although this still remains as an ongoing challenge. It has been reported that cellular CO levels could be measured using a selective fluorescent probe [53] or a genetically-encoded fluorescent probe containing a CO-sensing heme protein from Rhodospirillum rubrum [54] .
Conclusion
CORM-2 had dual effects on intracellular calcium regulation in 16HBE14o-cells. At higher concentrations, CORM-2 stimulated the PLC/IP 3 /calcium pathway to increase [Ca 2+ ] i , whereas at lower concentrations, CORM-2 inhibited calcium signaling induced by P2Y receptor agonists in an sGC/PKG-dependent manner. P2Y receptor agonists stimulated the release of two important pro-inflammatory cytokines, IL-6 and IL-8, and this process was calcium-dependent [7] . Therefore, CO might exert its anti-inflammatory effect in human bronchial epithelial cells by regulating the P2Y receptor-mediated calcium-signaling pathway. Thus, CO might act as an important regulator of calcium homeostasis in human airway epithelia.
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
